Conditions: Migraine
Keywords: migraine treatment satisfaction
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 246
Healthy volunteers: no

Brief summary:
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.

Detailed description:
Single arm, open-label, multicenter study to evaluate the treatment satisfaction, treatment confidence, and subject preference for Sumavel DosePro in adult subjects diagnosed with migraines and currently treated with triptans. Subjects will treat up to 4 migraines over a 60 day period and complete migraine diaries and questionnaires.

Arms:
arm 1: Single arm study (Sumavel DosePro)

Interventions: intervention 1: Sumavel DosePro intervention 2: Sumatriptan
Intervention descriptions: intervention 1: Needle free delivery system containing 0.5 mL of solution of 6 mg sumatriptan, subcutaneous administration intervention 2: subcutaneous injection, 6 mg, per migraine attack, no more than two administrations within a 24 hr period

Protocol document: